SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Galena Biopharma Presents Final Landmark 60-Month Results From NeuVax(TM) Phase 1/2 Trials at the 35th Annual CTRC-American Association for Cancer Research San Antonio Breast Cancer Symposium